NICE green lights two blood cancer therapies for NHS use
BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
What's Your Reaction?
